Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial

類似資料

• Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
  著者:: Wang, Yilong, 等
  出版事項: (2019)
• Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial
  著者:: Jing, Jing, 等
  出版事項: (2018)
• Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
  著者:: Pan, Yuesong, 等
  出版事項: (2014)
• Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
  著者:: Yang, Yingying, 等
  出版事項: (2018)
• Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE
  著者:: Liu, Liping, 等
  出版事項: (2015)